Novo Nordisk A/S buy mnake
Summary
This prediction ended on 31.01.14 with a price of €29.02. The BUY prediction by mnake finished with a performance of 16.05%. mnake has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novo Nordisk A/S | - | - | - | - |
iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by mnake for this prediction
In the thread Novo Nordisk A/S diskutieren
guter Einstiegskurs
unter 125 Euro ist das Papier aus meiner Sicht einen Kauf wert, es wird evtl. nochmal Rückschläge geben, mitelfristig sehe ich hier noch viel Potential
Stopped prediction by mnake for Novo Nordisk A/S
Novo Nordisk A/S
12.08.16
11.11.16
11.11.16